VVOS
Vivos Therapeutics Inc

5,604
Loading...
Loading...
News
all
press releases
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +218.52% and +66.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago
News Placeholder
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
chainwire·4mo ago
News Placeholder
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive sleep apnea and snoring in children aged 6-17. read more...
Benzinga·1y ago
News Placeholder
Q4 2023 Vivos Therapeutics Inc Earnings Call Transcript
Related Stocks: NAS:VVOS...
GuruFocus·1y ago
News Placeholder
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript...
SeekingAlpha·1y ago
News Placeholder
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·1y ago
News Placeholder
VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips VVOS stock results show that Vivos Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth...
InvestorPlace·1y ago
News Placeholder
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
Call Scheduled for Today, Thursday, March 28, 2024 at 5:00 pm ETLITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ( Vivos or the Company ) (NASDAQ: VVOS), a leading...
Globe Newswire·1y ago

Latest VVOS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.